Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 10.25
-0.09 (-0.87%)
Aug 1, 2025, 3:14 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 513.54 million as of August 1, 2025. Its market cap has decreased by -57.02% in one year.
Market Cap
513.54M
Enterprise Value
526.91M
Revenue
1.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.25
Market Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 513.54M, a decrease of -85.47%. That is a compound annual growth rate of -21.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 513.54M | -59.71% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | 3.44B | 372.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.19B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |